{'fraction_non_alphanumeric': 0.026392961876832845, 'fraction_numerical': 0.01466275659824047, 'mean_word_length': 6.041237113402062, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Potentiating effects of verapamil on cardiovascular teratogenicity of phenobarbital in the chick embryos.

Teratogenic to subteratogenic doses of phenobarbital were administered to young chick embryos together with a calcium-blocking agent, verapamil, at doses where it alone induces no cardiovascular malformations. The cardiovascular teratogenicity of phenobarbital was significantly potentiated by verapamil (5 X 10(-11), 1 X 10(-10) mol). The alteration of calcium movement into the cell and/or depressed cardiac function following impaired calcium transport by verapamil are suggested as modus operandi in the potentiation of phenobarbital-induced cardiovascular malformations.